<h1>Chand Rameshbhai Kanabar Resigns as Independent Director from Curis Lifesciences</h1>
Curis Lifesciences Limited announced the resignation of Mr. Chand Rameshbhai Kanabar, who served as an Independent Director on the Board. His resignation is effective from July 3, 2026.
The company confirmed that Mr. Kanabar resigned due to his pre-occupancy and increased professional commitments. The independent director also provided a confirmation stating that there are no other material reasons for his departure besides those mentioned.
Mr. Kanabar held directorships in several entities outside of Curis Lifesciences Limited, including Accretion Pharmaceuticals Limited, Kian-M Export Limited, and Golden Sparrow Consultancy Private Limited. He was involved in various committee memberships across these companies.
The details regarding the director's external roles and committee positions are summarized below:
| Company Name | Role Held | Committee Memberships |
|---|---|---|
| ACCRETION PHARMACEUTICALS LIMITED | Independent Director | Audit Committee, Nomination and Remuneration Committee, Stakeholder Relationship Committee, Corporate Social Responsibility Committee |
| KIAN-M EXPORT LIMITED | Independent Director | Audit Committee, Nomination and Remuneration Committee, Stakeholder Relationship Committee, Risk Management Committee |
| GOLDEN SPARROW CONSULTANCY PRIVATE LIMITED | Director | N/A |
CURIS Stock Price Movement
Curis Lifesciences Limited shares edged higher today, settling at ₹99.8 after gaining 0.4% in post-market trading. The stock closed up ₹0.40, with a volume of 1,000 shares traded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.